RBC Life Science and Technology Sr A (RBF274)
63.58
+0.06
(+0.10%)
CAD |
Dec 24 2025
RBF274 Asset Allocations & Exposures
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.88% |
| Stock | 98.88% |
| Bond | 0.24% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Market Capitalization
As of November 30, 2025
| Large | 90.39% |
| Mid | 6.66% |
| Small | 2.95% |
Region Exposure
| Americas | 95.95% |
|---|---|
|
North America
|
95.28% |
| Canada | 1.53% |
| United States | 93.75% |
|
Latin America
|
0.67% |
As of November 30, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 3.41% |
|---|---|
| United Kingdom | 0.49% |
|
Europe Developed
|
2.92% |
| Belgium | 0.43% |
| Ireland | 1.60% |
| Netherlands | 0.88% |
| Sweden | 0.00% |
| Switzerland | 0.00% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.39% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
| Australia | 0.00% |
|
Asia Developed
|
0.21% |
| Singapore | 0.00% |
| Taiwan | 0.21% |
|
Asia Emerging
|
0.17% |
| China | 0.17% |
| Unidentified Region | 0.25% |
|---|
Stock Sector Exposure
| Cyclical |
|
2.05% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.84% |
| Financials |
|
0.94% |
| Real Estate |
|
0.27% |
| Sensitive |
|
78.91% |
| Communication Services |
|
19.59% |
| Energy |
|
0.00% |
| Industrials |
|
1.26% |
| Information Technology |
|
58.06% |
| Defensive |
|
19.03% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
19.03% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.01% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
0.01% |
As of November 30, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |